FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market
CNBC Top News ·
The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.
The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.
Original source: CNBC Top News
Mentioned
Eli Lilly · GLP-1 · FDA · Novo Nordisk · Wegovy